Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

NCT01164540 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

3000

Enrollment

INDUSTRY

Sponsor class

Stopped Due to discussion regarding the design of the study.

Conditions

Venous Thrombosis
Pulmonary Embolism

Interventions

DRUG: Rosuvastatin (AZD4522)
DRUG: Placebo

Sponsor

AstraZeneca